⌘K

Login Start Free

Home/Filings/4/0001209191-15-022578

4//SEC Filing

Anacor Pharmaceuticals, Inc. 4

Accession 0001209191-15-022578

CIK 0001411158operating

View on SEC.gov Company Profile

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 7:22 PM ET

Size

13.9 KB

Accession

0001209191-15-022578

Insider Transaction Report

Form 4

Period: 2015-03-04

Anacor Pharmaceuticals, Inc.ANAC

VP & Interim Head of Drug Deve

Transactions

Exercise/Conversion
Common Stock
2015-03-04$7.25/sh+4,952$35,902→ 34,039 total
Sale
Common Stock
2015-03-04$45.00/sh−4,952$222,840→ 29,087 total
Exercise/Conversion
Common Stock
2015-03-04$7.55/sh+48$362→ 29,135 total
Sale
Common Stock
2015-03-04$45.00/sh−48$2,160→ 29,087 total
Exercise/Conversion
Stock Option (right to buy)
2015-03-04$7.25/sh−4,952$35,902→ 0 total
Exercise: $7.25Exp: 2018-03-26→ Common Stock (4,952 underlying)
Exercise/Conversion
Stock Option (right to buy)
2015-03-04$7.55/sh−48$362→ 13,552 total
Exercise: $7.55Exp: 2020-08-20→ Common Stock (48 underlying)

Footnotes (2)

[F1]This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
[F2]This option is fully vested and exercisable.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Anacor Pharmaceuticals, Inc.

CIK 0001411158

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001411158

Filing Metadata

Form type: 4
Filed: Mar 3, 7:00 PM ET
Accepted: Mar 4, 7:22 PM ET
Size: 13.9 KB

View on SEC.gov